Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.20.2
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of intangible assets

    September 30,     December 31,  
    2020     2019  
Intangibles with finite lives:            
Intellectual property   $ 2,101     $ 2,101  
Less: accumulated amortization – intellectual property     (1,362 )     (1,205 )
Total intangible assets, net   $ 739     $ 896  
Schedule of disaggregation of revenues

    Three months ended September 30,  
Product Type   2020     2019  
Myos Canine Muscle Formula® (1)   $ 376     $ 132  
Yolked® (2)     72       108  
Longevity (includes Qurr® (3) and Physician Muscle Health Formula (4) brands)     9       10  
White Label     28       100  
Total Net Revenues   $ 485     $ 350  

 

Our net revenues by product type are presented below for the nine months ended September 30, 2020 and 2019.

 

    Nine months ended September 30,  
Product Type   2020     2019  
Myos Canine Muscle Formula® (1)   $ 853     $ 282  
Yolked® (2)     176       229  
Longevity (includes Qurr® (3) and Physician Muscle Health Formula (4) brands)     19       42  
White Label     56       100  
Total Net Revenues   $ 1,104     $ 653  

 

(1) Launched in June 2018
(2) Launched in March 2018
(3) Launched in March 2017
(4) Launched in May 2016; relaunched in December 2019